Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a large growth in short interest in March. As of March 13th, there was short interest totaling 4,541 shares, a growth of 1,626.6% from the February 26th total of 263 shares. Based on an average trading volume of 11,657 shares, the short-interest ratio is currently 0.4 days. Based on an average trading volume of 11,657 shares, the short-interest ratio is currently 0.4 days.
Carl Zeiss Meditec Stock Performance
Shares of OTCMKTS CZMWY opened at $27.70 on Wednesday. Carl Zeiss Meditec has a fifty-two week low of $26.65 and a fifty-two week high of $76.25. The business has a 50 day moving average price of $32.48 and a two-hundred day moving average price of $43.97.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on CZMWY shares. The Goldman Sachs Group downgraded shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a research report on Tuesday, January 20th. Sanford C. Bernstein cut shares of Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th. One analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold”.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Read More
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
